COMMONWEALTH EQUITY SERVICES, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$284
-17.9%
13,605
-5.9%
0.00%0.0%
Q2 2023$346
+29.6%
14,455
+1.7%
0.00%0.0%
Q1 2023$267
+20.8%
14,207
+2.0%
0.00%0.0%
Q4 2022$221
-99.9%
13,930
+6.6%
0.00%0.0%
Q3 2022$213,000
+12.1%
13,065
-3.4%
0.00%
Q2 2022$190,000
-41.5%
13,523
+0.7%
0.00%
-100.0%
Q1 2022$325,000
-0.9%
13,426
-4.5%
0.00%0.0%
Q4 2021$328,000
+37.8%
14,053
-2.2%
0.00%0.0%
Q3 2021$238,000
-37.0%
14,372
-7.4%
0.00%0.0%
Q2 2021$378,000
-6.4%
15,513
-1.0%
0.00%0.0%
Q1 2021$404,000
-52.1%
15,663
-0.9%
0.00%
-66.7%
Q4 2020$844,000
+32.9%
15,798
+2.6%
0.00%
+50.0%
Q3 2020$635,000
-7.4%
15,405
+8.7%
0.00%
-33.3%
Q2 2020$686,000
+10.3%
14,166
-3.9%
0.00%0.0%
Q1 2020$622,000
-0.2%
14,741
+1.1%
0.00%
+50.0%
Q4 2019$623,000
+34.0%
14,581
+12.8%
0.00%0.0%
Q3 2019$465,000
+26.4%
12,931
-6.1%
0.00%0.0%
Q2 2019$368,000
-0.8%
13,777
-0.5%
0.00%0.0%
Q1 2019$371,000
+64.9%
13,846
-0.8%
0.00%
+100.0%
Q4 2018$225,000
-22.4%
13,956
-0.1%
0.00%0.0%
Q3 2018$290,000
+40.8%
13,970
+3.7%
0.00%0.0%
Q2 2018$206,000
-34.4%
13,467
-3.7%
0.00%
-50.0%
Q1 2018$314,00013,9900.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders